ARHGAP1 and colorectal carcinoma: Tian T et al. demonstrated that ARHGAP5, a member of the RhoGAP family, could promote the progression of EMT in colorectal cancer (CRC) cells via negatively regulating RhoA activity, which may serve as a hypothetical theoretical basis of RhoGAP subsequent exploration [25].